Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma

Bone Marrow Transplant. 2016 Sep;51(9):1249-52. doi: 10.1038/bmt.2016.100. Epub 2016 Apr 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antimetabolites, Antineoplastic / toxicity
  • Central Nervous System Neoplasms / prevention & control*
  • Child
  • Cytarabine / administration & dosage*
  • Cytarabine / toxicity
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia / pathology*
  • Liposomes
  • Lymphoma, Non-Hodgkin / pathology*
  • Neoplasm Invasiveness / prevention & control*
  • Treatment Outcome
  • Young Adult

Substances

  • Antimetabolites, Antineoplastic
  • Liposomes
  • Cytarabine